Sort
130,381 grants matching “hiv”
AFTERCARE TO REDUCE RELAPSE AND RISK OF HIV INFECTION
$778,953Friends Research Institute, Inc. · R01 · FY2000 · DA
The Center for the Global Demography of Aging
$778,949David E Bloom · Harvard School Of Public Health · P30 · FY2014 · AG
Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persisters
$778,923Petros C Karakousis · Johns Hopkins University · R01 · FY2024 · AI
Effective CMV-based SIV vaccine regimens for newborn infants via IL-10 modulation
$778,922Dennis J Hartigan-O'Connor · University Of California At Davis · R01 · FY2020 · AI
Impact of the Intestinal Microbiome on HIV/SIV Vaccines
$778,914Megan T Baldridge · Washington University · R01 · FY2019 · OD
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB
$778,882Neel Rajnikant Gandhi · Albert Einstein College Of Medicine · R01 · FY2011 · AI
Novel Stigma/Structural Interventions for Increasing HIV/STI Testing Among BMSM
$778,860Lisa A Eaton · University Of Connecticut Storrs · R01 · FY2017 · MH
Club Drug Use and Risky Behaviors Among Men
$778,853Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · DA
Fcgamma receptor-mediated suppression of immunodeficiency virus replication
$778,850David T Evans · University Of Wisconsin-Madison · R01 · FY2015 · AI
Effects of CSF1R blockade on repopulation of SIV reservoirs from the CNS to the periphery after antiretroviral therapy interruption
$778,847Kenneth C Williams · Boston College · R01 · FY2021 · NS
Papillomavirus Virion Proteins and Vaccines
$778,823Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Infant immune mechanisms of HIV reservoir size and decay
$778,821Grace C John-Stewart · University Of Washington · R01 · FY2017 · HD
Multi-omic dissection of the transcriptional, epigenetic, and proteomic signatures of cells infected with latent HIV
$778,783Francisco J. Quintana · Brigham And Women'S Hospital · R01 · FY2020 · AI
The Impact of Pre-exisiting SIV on Host Immunity to M tuberculosis in Macaques
$778,756Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AI
HIV-1 Env protein structure and function assessed by parallel smFRET and cryoET
$778,747Walther H Mothes · Yale University · R37 · FY2025 · AI
Eradicating Latent SIV from the CNS by CCR5 Inhibition
$778,708Joseph L Mankowski · Johns Hopkins University · R01 · FY2014 · NS
Elucidating the role of B cell mediated trans infection in the establishment of the latent HIV-1 reservoir
$778,686Nicolas P Sluis-Cremer · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$778,661Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Scaling Out and Scaling Up the Systems Analysis and Improvement Approach to Optimize the Hypertension Diagnosis andCare Cascade for HIV-infected Individuals (SCALE SAIA HTN)
$778,610Ana Olga Mocumbi · Eduardo Mondlane University · UH3 · FY2022 · HL
HIV Genomic Aging Project in Oncology (HIV-GAP)
$778,598Anna Coghill · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
PEDIATRICS AIDS CLINICAL TRIALS GROUP
$778,575Columbia University Health Sciences · U01 · FY2004 · AI
Viral Testing
$778,567Carlos A Sariol · University Of Puerto Rico Med Sciences · U42 · FY2025 · OD
Persistent HIV expression induced type I IFN responses and inflammaging
$778,565Suryaram Gummuluru · Boston University Medical Campus · R01 · FY2021 · AG
Identification of the Initial Targets of Transmission
$778,558Thomas Hope · Northwestern University At Chicago · R37 · FY2021 · AI
Indiana HIV Surveillance System
$778,520Daniel Hillman · Indiana State Department Of Health · U62 · FY2015 · PS